Sichuan Huiyu Pharmaceutical Co., Ltd.
Status: Publicly traded
Last reviewed: October 2026
Direct answer
Sichuan Huiyu Pharmaceutical Co., Ltd. is publicly traded on SHH under the ticker 688553.SS.
Sichuan Huiyu Pharmaceutical Co., Ltd. researches, develops, produces, and sells anti-tumor injection in China and internationally. It offers injection drug products, such as pemetrexed disodium, methrotrexate, docetaxel, azacitidine, oxaliplatin, cyclophosphamide, irinotecan hydrochloride, paclitaxel, bendamustine hydrochloride, decitabine, palonosetron hydrochloride, plerixafor, levetiracetam concentrated...
Can you invest in Sichuan Huiyu Pharmaceutical Co., Ltd.?
Yes. Sichuan Huiyu Pharmaceutical Co., Ltd. is publicly traded on SHH under the ticker 688553.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Sichuan Huiyu Pharmaceutical Co., Ltd.
Detailed equity research is provided by MarketSnap.